SNT 9.09% 2.4¢ syntara limited

re: positive phase iii results This is an interesting article...

  1. 241 Posts.
    re: positive phase iii results This is an interesting article http://www.businessday.com.au/business/dont-give-up-on-pharmaxis-yet-20100623-yz6r.html

    Shaw Stockbroking analyst Matthias Smith left his Pharmaxis share price target unchanged at $4.30 after drilling into the data, commenting that he would be ''very surprised if further data is required for FDA approval''.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.002(9.09%)
Mkt cap ! $28.65M
Open High Low Value Volume
2.2¢ 2.5¢ 2.2¢ $12.04K 509.9K

Buyers (Bids)

No. Vol. Price($)
1 82668 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 100000 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.